Celani M G, Ceravolo M G, Duca E, Minciotti P, Caputo N, Orlandini M, Ricci S, Provinciali L
Clinica Neurologica, Perugia University Hospital, Italy.
J Neurol. 1992 Aug;239(7):411-3.
Since the clinical distinction between haemorrhagic and ischaemic stroke cannot be achieved with a simple clinical evaluation, and it is virtually impossible to submit all stroke patients to CT, a weighted clinical score may offer some advantages to physicians who are involved in stroke management. The Allen score (also referred to as the Guy's Hospital score), a validated clinical score, has been tested in two different clinical settings, comprising 289 patients. When only the values under 4 and those over 24 are taken into account (i.e. greater than 90% probability of ischaemia and haemorrhage), the global accuracy of the score is 97%, and the diagnostic gain (given a pretest probability for haemorrhage of 11% and a likelihood ratio of 194) is 85%. Therefore, we conclude that this simple clinical method can be used for epidemiological studies of stroke incidence and outcome, as well as for a first bedside screening to decide which patients should have priority for CT.
由于通过简单的临床评估无法实现出血性和缺血性中风的临床区分,而且几乎不可能让所有中风患者都接受CT检查,因此加权临床评分可能会为参与中风管理的医生带来一些优势。艾伦评分(也称为盖伊医院评分)是一种经过验证的临床评分,已在包括289名患者的两种不同临床环境中进行了测试。当仅考虑4分以下和24分以上的值时(即缺血和出血的可能性大于90%),该评分的总体准确率为97%,诊断增益(给定出血的预测试概率为11%,似然比为194)为85%。因此,我们得出结论,这种简单的临床方法可用于中风发病率和转归的流行病学研究,以及作为首次床边筛查,以确定哪些患者应优先进行CT检查。